bluebird bio, Inc. (BLUE)
NASDAQ: BLUE · IEX Real-Time Price · USD
1.100
+0.050 (4.76%)
Jul 22, 2024, 11:37 AM EDT - Market open
bluebird bio Employees
bluebird bio had 323 employees as of December 31, 2022. The number of employees decreased by 195 or -37.64% compared to the previous year.
Employees
323
Change (1Y)
-195
Growth (1Y)
-37.64%
Revenue / Employee
$67,263
Profits / Employee
-$282,251
Market Cap
211.05M
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
P3 Health Partners | 400 |
Personalis | 225 |
Biodesix | 217 |
CVRx, Inc. | 200 |
Genfit | 159 |
Caribou Biosciences | 158 |
Shattuck Labs | 75 |
Renovaro Biosciences | 12 |
BLUE News
- 9 days ago - BLUE ALERT: Bragar Eagel & Squire, P.C. is Investigating Bluebird bio Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewsWire
- 18 days ago - bluebird bio Reports Inducement Grant to CFO James Sterling Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 7 weeks ago - 2Flo Ventures Announces Addition of Renowned Life Sciences Executive Charlotte Jones-Burton, MD, MS as a Partner - PRNewsWire
- 7 weeks ago - Bluebird bio appoints new CFO to oversee financial restatements - Reuters
- 7 weeks ago - bluebird bio Appoints O. James Sterling as Chief Financial Officer - Business Wire
- 2 months ago - The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against bluebird bio, Inc. (BLUE) - Business Wire
- 2 months ago - Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 28, 2024 in bluebird bio Lawsuit - BLUE - PRNewsWire
- 2 months ago - SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against bluebird bio, Inc. - BLUE - PRNewsWire